NCT07818135

Brief Summary

This study compares two established robotic surgical approaches for removing lung tumors in adults with non-small cell lung cancer: biportal robotic-assisted thoracic surgery (biRATS) and multiportal robotic-assisted thoracic surgery (multiRATS). Participants are assigned at random to one of the two approaches. The study will compare surgical safety, recovery after surgery, pain, length of hospital stay, quality of life, and other clinical outcomes during 12 months of follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable nonsmall-cell-lung-cancer

Timeline
16mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Feb 2028

Study Start

First participant enrolled

January 15, 2026

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 14, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

September 14, 2026

Status Verified

September 1, 2026

Enrollment Period

2 years

First QC Date

September 1, 2026

Last Update Submit

September 7, 2026

Conditions

Keywords

Robotic-Assisted Thoracic SurgeryPulmonary ResectionbiRATSmultiRATS

Outcome Measures

Primary Outcomes (1)

  • Incidence of Intraoperative and Immediate Postoperative Complications

    Proportion of participants with intraoperative or immediate postoperative complications, classified by Clavien-Dindo grade. Events include, among others, prolonged air leak, pleuropulmonary infection, pneumothorax, postoperative hemorrhage, chylothorax, respiratory failure, wound infection, readmission, and perioperative death.

    From surgery through hospital discharge, up to 30 days

Secondary Outcomes (8)

  • Intraoperative Blood Loss

    During surgery

  • Length of Hospital Stay

    From surgery through hospital discharge, up to 30 days

  • Postoperative Pain Intensity (Visual Analog Scale)

    From baseline through 12 months after surgery

  • Neuropathic Pain (Douleur Neuropathique 4 Questionnaire)

    From baseline through 12 months after surgery

  • Health Status (EuroQol 5-Dimension 5-Level Questionnaire)

    From baseline through 12 months after surgery

  • +3 more secondary outcomes

Study Arms (2)

biRATS

EXPERIMENTAL

Biportal robotic-assisted thoracic surgery for pulmonary resection using two access incisions.

Procedure: Biportal Robotic-Assisted Thoracic Surgery

multiRATS

ACTIVE COMPARATOR

Multiportal robotic-assisted thoracic surgery for pulmonary resection using multiple access ports.

Procedure: Multiportal Robotic-Assisted Thoracic Surgery

Interventions

Pulmonary resection performed with a biportal robotic-assisted thoracic surgery approach using two access incisions.

biRATS

Pulmonary resection performed with a multiportal robotic-assisted thoracic surgery approach using multiple access ports.

multiRATS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older, of any sex.
  • Non-small cell lung cancer considered clinically resectable, confirmed preoperatively or during surgery.
  • Candidate for pulmonary resection by robotic thoracic surgery.
  • Written informed consent.

You may not qualify if:

  • Declines participation or cannot provide written informed consent.
  • Thoracic anatomical abnormalities that preclude or materially affect robotic surgery.
  • Active thoracic infection.
  • Surgery not performed by a participating surgeon with comparable experience in biRATS and multiRATS.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, 08907, Spain

RECRUITING

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Carlos Déniz Armengol, MD, PhD

    Hospital Universitari de Bellvitge

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carlos Déniz Armengol, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants are partially masked to the allocated surgical approach by standardized dressings maintained for 48 hours after surgery.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two-arm parallel-group trial comparing biportal RATS with multiportal RATS for pulmonary resection.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Thoracic Surgeon

Study Record Dates

First Submitted

September 1, 2026

First Posted

September 14, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

September 14, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because of data-protection and institutional-governance requirements.

Locations